Type of Study:

Observational

Study Design:

Observational Model: Case-Only, Time Perspective: Prospective

Outcome Measure:

The difference (in percent) in false positive DXM-tests comparing the outcome of all tests with all tests excluding those with s-DXM below the the cut-off specified below.

Outcome Description:

The s-DXM cut-off will be defined a priori from ROC analysis on patients that inadequately suppress s-cortisol categorized as having Cushing's syndrome or being healthy. DXM, dexamethasone; DXM-test, short 1mg dexamethasone suppression test.

Outcome Time Frame:

1 year

Safety Issue:

No

Principal Investigator

Grethe Åstrøm Ueland, MD

Investigator Role:

Study Chair

Investigator Affiliation:

Haukeland University Hospital

Authority:

Norway: Regional Ethics Commitee

Study ID:

2011/1810

NCT ID:

NCT01504555

Start Date:

October 2011

Completion Date:

December 2012

Related Keywords:

• Cushing's Syndrome
• Adrenal Incidentalomas
• Alcoholism
• Obesity
• hypercortisolism, dexamethasone, alcoholism,obesity.
• Alcoholism
• Cushing Syndrome
• Obesity
• Adrenocortical Adenoma
• Adrenal Gland Neoplasms